FI962948A - Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi - Google Patents

Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi Download PDF

Info

Publication number
FI962948A
FI962948A FI962948A FI962948A FI962948A FI 962948 A FI962948 A FI 962948A FI 962948 A FI962948 A FI 962948A FI 962948 A FI962948 A FI 962948A FI 962948 A FI962948 A FI 962948A
Authority
FI
Finland
Prior art keywords
active substances
pharmaceutically active
sparingly soluble
soluble pharmaceutically
dissolving
Prior art date
Application number
FI962948A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962948A0 (fi
Inventor
Dadi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of FI962948A0 publication Critical patent/FI962948A0/fi
Publication of FI962948A publication Critical patent/FI962948A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI962948A 1994-01-24 1996-07-23 Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi FI962948A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (2)

Publication Number Publication Date
FI962948A0 FI962948A0 (fi) 1996-07-23
FI962948A true FI962948A (fi) 1996-07-23

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962948A FI962948A (fi) 1994-01-24 1996-07-23 Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi

Country Status (14)

Country Link
EP (1) EP0741560A1 (xx)
JP (1) JPH09508128A (xx)
CN (1) CN1138827A (xx)
AU (1) AU706890B2 (xx)
BR (1) BR9506564A (xx)
CA (1) CA2181241C (xx)
CZ (1) CZ210496A3 (xx)
FI (1) FI962948A (xx)
MX (1) MX9602955A (xx)
NO (1) NO963052L (xx)
NZ (1) NZ279443A (xx)
PL (1) PL315635A1 (xx)
SK (1) SK96196A3 (xx)
WO (1) WO1995019759A1 (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
CA2318128C (en) 1998-01-20 2008-10-14 Applied Analytical Industries, Inc. Oral liquid compositions
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (fr) * 1999-07-29 2003-05-09 So Ge Val Sa Composition antipyretique concentree et stabilisee a usage veterinaire destine a etre incorporee a l'alimentation des animaux ainsi que procede d'incorporation de cette composition a l'eau de boisson d'animaux
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (de) * 2000-03-07 2001-09-13 Bayer Ag Acetylsalicylsäure-Lösungen
KR20020069387A (ko) * 2001-02-26 2002-09-04 진양제약주식회사 호박산독실아민 조성물 및 이 조성물을 함유한 연질캅셀제제
NZ530889A (en) * 2001-07-31 2005-03-24 Wyeth Corp Use of sucralose as a sweetening agent combined with pH modulation of chemical formulations generates enhanced taste-masking effects
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (zh) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 一种难溶性药物微丸的制备方法及包含该微丸的制剂
EP1959935A2 (en) * 2005-10-26 2008-08-27 Banner Pharmacaps Inc. Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
DE102005053066A1 (de) 2005-11-04 2007-05-10 Basf Ag Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
JP2009523119A (ja) * 2005-12-09 2009-06-18 ビーエーエスエフ ソシエタス・ヨーロピア 水に溶けにくい化合物のための可溶化剤としてのポリビニルラクタム−ポリオキシアルキレンブロックコポリマーの使用
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (ja) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd ソフトカプセル
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
RS55491B2 (sr) * 2010-01-28 2020-11-30 Eagle Pharmaceuticals Inc Formulacije bendamustina
RS65177B1 (sr) 2012-03-20 2024-03-29 Eagle Pharmaceuticals Inc Formulacije bendamustina
EP2827863B1 (en) 2012-03-20 2019-01-16 Eagle Pharmaceuticals, Inc. Liquid composition for use in a method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
BR112015018838B1 (pt) 2013-02-28 2020-12-15 Pfizer Inc. Composição oral líquida com estabilidade melhorada e seu processo para a preparação
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (zh) * 2015-06-29 2017-06-11 永信藥品工業股份有限公司 一種製作難溶藥物固體劑型的方法
EP3364955B1 (en) 2015-10-09 2022-04-20 RB Health (US) LLC Pharmaceutical formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
NO963052L (no) 1996-09-24
CN1138827A (zh) 1996-12-25
CA2181241C (en) 2000-04-25
EP0741560A1 (en) 1996-11-13
PL315635A1 (en) 1996-11-25
SK96196A3 (en) 1997-03-05
CZ210496A3 (en) 1996-12-11
AU1607595A (en) 1995-08-08
WO1995019759A1 (en) 1995-07-27
JPH09508128A (ja) 1997-08-19
FI962948A0 (fi) 1996-07-23
MX9602955A (es) 1997-06-28
AU706890B2 (en) 1999-07-01
NO963052D0 (no) 1996-07-22
CA2181241A1 (en) 1995-07-27
BR9506564A (pt) 1997-09-02
NZ279443A (en) 1998-04-27

Similar Documents

Publication Publication Date Title
FI962948A (fi) Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi
NO961136D0 (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
FI946173A0 (fi) Menetelmä lääkeaineiden antotehon parantamiseksi muunnettujen saponiinien avulla
NO20010556D0 (no) Fremgangsmåte for oftalmisk administrering
EE9800116A (et) Farmatseutiliselt aktiivsed kinasoliini ühendid
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
DE69525148D1 (de) Pharmazeutische formulierung
DE69514087D1 (de) Pharmazeutisch aktive substituierte aromatische verbindungen
BR9504060A (pt) Composto e formulação farmacêutica
DK0780369T3 (da) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer
NO974618D0 (no) Farmasöytiske preparater for intranasal administrasjon
DE69513671D1 (de) Arzneimittel
NO984106D0 (no) Azolobenzazepin-derivater som neurologisk aktive midler
NO980546D0 (no) Farmasöytiske midler
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
BR9708949A (pt) Composto formulação farmacêutica e processos de preparação dos mesmos e de tratamento de um mamífero incluindo o homem
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse
ITMI940506A0 (it) Derivati chinzolilamminici attivi come alfa-antagonisti
FI943201A (fi) Vaikuttavaa ainetta luovuttava laite
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
DE69528843D1 (de) Pharmakologisch aktive 2-mercaptobenzimidazolderivate
FI103744B1 (fi) Menetelmä ja järjestely aktiivisuotimen kalibroimiseksi
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
IT1273469B (it) Montante laterale per quadro dei licci